Park Medi World Ltd (PARKHOSPS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 544645 | NSE: PARKHOSPS | Hospital & Healthcare Services |

Park Medi World Share Price

155.40 7.25 4.89%
as on 18-Dec'25 16:59

DeciZen - make an informed investing decision on Park Medi World

Based on:

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Park Medi World stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
891.36
Market Cap:
6,399.1 Cr.
52-wk low:
146.9
52-wk high:
165.8

Is Park Medi World Ltd an attractive stock to invest in?

1. Is Park Medi World Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Park Medi World Ltd is a below average quality company.

2. Is Park Medi World Ltd undervalued or overvalued?

The key valuation ratios of Park Medi World Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Park Medi World Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Park Medi World Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Park Medi World:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Park Medi World Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 16.6%11.6%11.8%8.5%-
Value Creation
Index
0.2-0.1-0.1-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 11010289.691.692
Sales YoY Gr.--6.8%-12.6%2.3%-
Adj EPS 0.20.20.20.20.2
YoY Gr.--13.6%5.3%-5%-
BVPS (₹) 2.52.62.832.9
Adj Net
Profit
8.47.17.57.27
Cash Flow from Ops. 29.545.448.19.3-
Debt/CF from Ops. 3.32.52.617-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-5.9%2.3%
Adj EPS NANA-4.8%-5%
BVPSNANA5.4%7.2%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
8.67.27.36.65.8
Op. Profit
Mgn %
18.823.428.826.4NAN
Net Profit
Mgn %
7.66.98.47.98
Debt to
Equity
11.11.21.4-
Working Cap
Days
02942351780
Cash Conv.
Cycle
08433140

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 5.80%

Sales growth has been subdued in last 3 years -5.91%

Net Profit has been subdued in last 3 years -4.77%

Debt to equity has increased versus last 3 years average to 1.38

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Park Medi World Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 4.8
TTM Sales (₹ Cr.) 91.6 1,394
BVPS (₹.) 2.9 24.7
Reserves (₹ Cr.) 37 981
P/BV 51.73 6.00
PE 891.36 31.19
From the Market
52 Week Low / High (₹) 146.85 / 165.75
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 6,399
Equity (₹ Cr.) 86.4
Face Value (₹) 2
Industry PE 87.8

Management X-Ray of Park Medi World:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Park Medi World - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Park Medi World

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales1101029092
Operating Expenses 89786467
Manufacturing Costs2141716
Material Costs20191516
Employee Cost 15181617
Other Costs 33381718
Operating Profit 21242624
Operating Profit Margin (%) 18.8%23.4%28.7%26.4%
Other Income 15552
Interest 20131412
Depreciation 3555
Exceptional Items 0000
Profit Before Tax 1310139
Tax 4352
Profit After Tax 8777
PAT Margin (%) 7.6%6.9%8.4%7.8%
Adjusted EPS (₹)0.20.20.20.2
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 98100106114
Share Capital 77777777
Reserves 21243037
Minority Interest0000
Debt8899117145
Long Term Debt75353450
Short Term Debt13648394
Trade Payables6101415
Others Liabilities 37643944
Total Liabilities 229273277317

Fixed Assets

Gross Block44398289
Accumulated Depreciation245914
Net Fixed Assets 20347375
CWIP 851337
Investments 102148149149
Inventories0000
Trade Receivables44362233
Cash Equivalents 11946
Others Assets 43421618
Total Assets 229273277317

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 3045489
PBT 1310139
Adjustment 10141521
Changes in Working Capital 123024-20
Tax Paid -5-9-3-0
Cash Flow From Investing Activity -21-39-51-31
Capex -191-51-33
Net Investments -15-42-51
Others 13251
Cash Flow From Financing Activity -9-1-524
Net Proceeds from Shares 0000
Net Proceeds from Borrowing 19-40-721
Interest Paid -20-13-14-7
Dividend Paid 0000
Others -853169
Net Cash Flow -05-81

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)8.557.187.256.51
ROCE (%)16.5711.5511.768.47
Asset Turnover Ratio0.480.410.330.31
PAT to CFO Conversion(x)3.756.436.861.29
Working Capital Days
Receivable Days147142118111
Inventory Days1000
Payable Days114160299321

Park Medi World Ltd Stock News

Park Medi World Ltd FAQs

The current trading price of Park Medi World on 18-Dec-2025 16:59 is ₹155.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Dec-2025 the market cap of Park Medi World stood at ₹6,399.1.
The latest P/E ratio of Park Medi World as of 17-Dec-2025 is 891.4.
The latest P/B ratio of Park Medi World as of 17-Dec-2025 is 51.73.
The 52-week high of Park Medi World is ₹165.8 and the 52-week low is ₹146.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Park Medi World is ₹91.58 ( Cr.) .

About Park Medi World Ltd

Park Medi World was incorporated in New Delhi as ‘Park Medi World Private Limited’ as a private limited company on January 20, 2011. Subsequently, the company was converted to a public limited company and the name of the company has been changed to the present name, ‘Park Medi World Limited’, pursuant to a resolution passed by the board on November 15, 2024 and by the shareholders on November 18, 2024.

The company is one of the largest private hospital chains in North India. It offers multiple super specialty and specialty services, including internal medicine, neurology, urology, gastroentereology, general surgery, orthopedics and oncology. It operates a network of NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which some hospitals are also NABL accredited. The company has adopted a cluster-based approach to grow its network of hospitals leveraging the benefits of proximity between its hospitals leading to operational efficiencies and enabling it to benefit from economies of scale.

In order to ensure that its services remain affordable, the company actively pursue several strategic measures to manage its operating costs. These include employing modern medical technology to reduce recovery time, employing full-time doctors and consultants, nurses and medical staff, maintaining strong relationships with its vendors and leveraging economies of scale from its existing network. The company is led by its founder and Chairman Ajit Gupta, whose leadership and deep understanding of the healthcare landscape in India has laid the foundation for the company’s growth.

Business area of the company 

The company, along with its subsidiaries, is in the business of owning, managing and running medical facilities in order to provide comprehensive services and to undertake research including clinical research and development work required to promote, assist or engage in setting up hospitals.

Services of the company

  • Internal Medicine
  • Neurology
  • Urology
  • Gastroenterology
  • Cardiology
  • General Surgery
  • Orthopedic
  • Oncology
  • Other specialty service

Awards, accreditations and recognition 

  • 2017: Indian Excellence Award for ‘Best Multi-Specialty Hospital in Delhi-NCR and Haryana’ in ‘Healthcare & Business Sector’ was awarded to Park Hospital.
  • 2019: Healthcare Leadership Award for ‘Best Multi Super Speciality Hospital’ was awarded to Park Hospital, Gurgaon.
  • 2019: Award for ‘Most Valuable and Admirable Hospital’ was awarded to Park group of Hospitals by ET Now.

History and milestones

  • 2011: Incorporation of the company on January 20, 2011.
  • 2011:  Took over the running proprietorship business of Park Sunil Hospital, Delhi and/or Park Hospital, New Delhi from one of the Promoters, Ajit Gupta.
  • 2011: The company acquired Aggarwal Hospitals and Research Services Private Limited.
  • 2017: The company’s subsidiary, Park Medicenters acquired DMR Hospitals Private Limited.
  • 2020: The company acquired Blue Heavens Health Care Private Limited.
  • 2020: The company’s subsidiary, Kailash Super-Speciality Hospital Private Limited acquired 100% running business of ‘Kailash Hospital Behror’.
  • 2021: The company acquired Umkal Health Care Private Limited.
  • 2021: The company’s subsidiary, Park Medicity India Private Limited acquired Narsingh Hospital & Heart Institute Private Limited.
  • 2022: The company’s subsidiary, Park Medicenters & Institutions Private Limited acquired Ratangiri Innovations Private Limited.
  • 2023: The company’s subsidiary, Park Medicenters & Institutions Private Limited acquired R G S Healthcare Limited.
  • 2025: The company’s subsidiary, Aggarwal Hospitals and Research Services Private Limited acquired 55.00% share capital Devina Derma Private Limited.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×